4//SEC Filing
Tesi Raymond Joseph 4
Accession 0001213900-24-079121
CIK 0001711754other
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 8:48 PM ET
Size
7.6 KB
Accession
0001213900-24-079121
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Purchase
Common Stock Warrants (right to buy)
2024-09-12$0.13/sh+15,380$1,923→ 15,380 totalExercise: $6.40Exp: 2030-03-16→ Common Stock (15,380 underlying) - Purchase
Common Stock
2024-09-12$6.38/sh+15,380$98,048→ 1,554,106 total
Footnotes (1)
- [F1]The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $6.50, for an aggregate purchase price of $13,000,000 pursuant to a securities purchase agreement dated September 12, 2024. The Warrants are exercisable on or after March 16, 2025 and will terminate on March 16, 2030 unless such termination is accelerated pursuant to the terms of the Warrants (the "Termination Date"), provided, however, in the event that the Warrant is held by Insiders and the Termination Date is during a period that such Insiders are subject to a blackout with respect to trading in the Company's common stock, such Insiders will have an additional 60 days from the termination of the blackout to exercise the Warrant. The exercise price the Warrants is $6.40 per share subject to adjustment as provided in the Warrant.
Documents
Issuer
Inmune Bio, Inc.
CIK 0001711754
Entity typeother
Related Parties
1- filerCIK 0001767280
Filing Metadata
- Form type
- 4
- Filed
- Sep 15, 8:00 PM ET
- Accepted
- Sep 16, 8:48 PM ET
- Size
- 7.6 KB